Teva UK Ltd v Merck & Company Inc.
| Jurisdiction | England & Wales |
| Date | 2010 |
| Year | 2010 |
| Court | Chancery Division |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
6 cases
-
Regen Lab SA v Estar Medical Ltd
...must be shown to have been common general knowledge in the UK. He referred to Teva UK Ltd v Merck & Co Inc [2009] EWHC 2952 (Pat); [2010] FSR 17 in which Floyd J observed: “[103] … It would seem to me to be an odd result if a patent for the United Kingdom could survive if it was obvious in......
-
Regen Lab SA v Estar Medical Ltd
...must be shown to have been common general knowledge in the UK. He referred to Teva UK Ltd v Merck & Co Inc [2009] EWHC 2952 (Pat); [2010] FSR 17 in which Floyd J observed: “[103] … It would seem to me to be an odd result if a patent for the United Kingdom could survive if it was obvious in......
-
Generics (UK) Ltd trading as Mylan v Warner-Lambert Company LLC
...skilled in the art in the USA, but not to persons skilled in the art in the UK? In Teva UK Ltd v Merck & Co Inc [2009] EWHC 2952 (Pat), [2010] FSR 17 Floyd J (as he then was) said: "101. A question arises as to whether it is sufficient to establish that a particular fact was known in the U......
-
H. Lundbeck A/S (Claimant/Part 20 Defendant) v (1) Norpharma Spa (2) Infosint S/A (Defendants/Part 20 Claimants) (3) Lundbeck Ltd and Others (Third, Fourth and Fifth Parties/ Part 20 Defendants)
...that Mr Lykiardopoulos sought to characterise the necessary testing as a research project. He reminded me of what I said in Teva v Merck [2010] FSR 17 at [88]–[98] namely that the court should proceed "with caution" when faced with an obviousness attack based on the suggestion that the skil......
Request a trial to view additional results